MICHAEL SERNA: Open Payments
NPI 1548675135 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 10 payments from 6 companies in 2025. Trend: 2023 $299 · 2024 $116 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| BioXcel Therapeutics, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: FANAPT, INGREZZA, VRAYLAR, COBENFY, IGALMI, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
